{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:48:46Z","timestamp":1790088526680,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH106037"],"award-info":[{"award-number":["MH106037"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005337","name":"American Academy of Child and Adolescent Psychiatry","doi-asserted-by":"publisher","award":["Campaign for America's Kids"],"award-info":[{"award-number":["Campaign for America's Kids"]}],"id":[{"id":"10.13039\/100005337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40272-015-0153-1","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T07:36:02Z","timestamp":1449992162000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability"],"prefix":"10.1007","volume":"18","author":[{"given":"Eric T.","family":"Dobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Strawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"issue":"4","key":"153_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archgenpsychiatry.2011.160","volume":"69","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012;69(4):372\u201380.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"153_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","volume":"49","author":"KR Merikangas","year":"2010","unstructured":"Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"153_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1943-278X.2012.00091.x","volume":"42","author":"KA O\u2019Neil","year":"2012","unstructured":"O\u2019Neil KA, Puleo CM, Benjamin CL, Podell JL, Kendall PC. Suicidal ideation in anxiety-disordered youth. Suicide Life Threat Behav. 2012;42(3):305\u201317.","journal-title":"Suicide Life Threat Behav."},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jad.2014.07.009","volume":"168","author":"B Mars","year":"2014","unstructured":"Mars B, Heron J, Crane C, Hawton K, Kidger J, Lewis G, et al. Differences in risk factors for self-harm with and without suicidal intent: findings from the ALSPAC cohort. J Affect Disord. 2014;168:407\u201314.","journal-title":"J Affect Disord"},{"issue":"4","key":"153_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10802-007-9192-6","volume":"36","author":"TL Verduin","year":"2008","unstructured":"Verduin TL, Kendall PC. Peer perceptions and liking of children with anxiety disorders. J Abnorm Child Psychol. 2008;36(4):459\u201369.","journal-title":"J Abnorm Child Psychol"},{"issue":"3","key":"153_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1207\/s15374424jccp2703_2","volume":"27","author":"C Hansen","year":"1998","unstructured":"Hansen C, Sanders SL, Massaro S, Last CG. Predictors of severity of absenteeism in children with anxiety-based school refusal. J Clin Child Psychol. 1998;27(3):246\u201354.","journal-title":"J Clin Child Psychol."},{"issue":"3","key":"153_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1469-7610.1995.tb01300.x","volume":"36","author":"N Ialongo","year":"1995","unstructured":"Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S. The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. J Child Psychol Psychiatry. 1995;36(3):427\u201337.","journal-title":"J Child Psychol Psychiatry"},{"issue":"2","key":"153_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10578-007-0082-5","volume":"39","author":"AA Hughes","year":"2008","unstructured":"Hughes AA, Lourea-Waddell B, Kendall PC. Somatic complaints in children with anxiety disorders and their unique prediction of poorer academic performance. Child Psychiatry Hum Dev. 2008;39(2):211\u201320.","journal-title":"Child Psychiatry Hum Dev"},{"issue":"5","key":"153_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00004583-199705000-00017","volume":"36","author":"GA Bernstein","year":"1997","unstructured":"Bernstein GA, Massie ED, Thuras PD, Perwien AR, Borchardt CM, Crosby RD. Somatic symptoms in anxious-depressed school refusers. J Am Acad Child Adolesc Psychiatry. 1997;36(5):661\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"153_CR10","doi-asserted-by":"publisher","unstructured":"Benjamin CL, Harrison JP, Settipani CA, Brodman DM, Kendall PC. Anxiety and related outcomes in young adults 7 to 19 years after receiving treatment for child anxiety. J Consult Clin Psychol. 2013;81(5). doi:\n                    10.1037\/a0033048\n                    \n                  .","DOI":"10.1037\/a0033048"},{"issue":"1","key":"153_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","volume":"55","author":"DS Pine","year":"1998","unstructured":"Pine DS, Cohen P, Gurley D, Brook J, Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry. 1998;55(1):56\u201364.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"153_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00004583-199902000-00010","volume":"38","author":"EJ Costello","year":"1999","unstructured":"Costello EJ, Angold A, Keeler GP. Adolescent outcomes of childhood disorders: the consequences of severity and impairment. J Am Acad Child Adolesc Psychiatry. 1999;38(2):121\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"153_CR13","doi-asserted-by":"crossref","unstructured":"Merikangas KR, He J-P, Burstein M, Swendsen J, Avenevoli S, Case B, et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the national comorbidity survey\u2013adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50(1):32\u201345.","DOI":"10.1016\/j.jaac.2010.10.006"},{"issue":"3","key":"153_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamapsychiatry.2013.4186","volume":"71","author":"GS Ginsburg","year":"2014","unstructured":"Ginsburg GS, Becker EM, Keeton CP, Sakolsky D, Piacentini J, Albano AM, et al. Naturalistic follow-up of youths treated for pediatric anxiety disorders. JAMA Psychiatry. 2014;71(3):310\u20138.","journal-title":"JAMA Psychiatry."},{"issue":"3","key":"153_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.psc.2009.06.002","volume":"32","author":"K Beesdo","year":"2009","unstructured":"Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin N Am. 2009;32(3):483\u2013524.","journal-title":"Psychiatr Clin N Am."},{"key":"153_CR16","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013."},{"issue":"10","key":"153_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/j.1469-7610.2009.02092.x","volume":"50","author":"FV Van Oort","year":"2009","unstructured":"Van Oort FV, Greaves-Lord K, Verhulst FC, Ormel J, Huizink AC. The developmental course of anxiety symptoms during adolescence: the TRAILS study. J Child Psychol Psychiatry. 2009;50(10):1209\u201317.","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"153_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archgenpsychiatry.2009.177","volume":"67","author":"K Beesdo","year":"2010","unstructured":"Beesdo K, Pine DS, Lieb R, Wittchen HU. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry. 2010;67(1):47\u201357.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"153_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamapsychiatry.2014.655","volume":"71","author":"MA Waszczuk","year":"2014","unstructured":"Waszczuk MA, Zavos HM, Gregory AM, Eley TC. The phenotypic and genetic structure of depression and anxiety disorder symptoms in childhood, adolescence, and young adulthood. JAMA Psychiatry. 2014;71(8):905\u201316.","journal-title":"JAMA Psychiatry."},{"issue":"171","key":"153_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jad.2014.09.004","volume":"15","author":"AM Wehry","year":"2015","unstructured":"Wehry AM, McNamara RK, Adler CM, Eliassen JC, Croarkin P, Cerullo MA, et al. Neurostructural impact of co-occurring anxiety in pediatric patients with major depressive disorder: a voxel-based morphometry study. J Affect Disord. 2015;15(171):54\u20139.","journal-title":"J Affect Disord"},{"issue":"3","key":"153_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/archgenpsychiatry.2008.545","volume":"66","author":"K Beesdo","year":"2009","unstructured":"Beesdo K, Lau JY, Guyer AE, McClure-Tone EB, Monk CS, Nelson EE, et al. Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry. 2009;66(3):275\u201385.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"153_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archpsyc.58.6.597","volume":"58","author":"WA Vollebergh","year":"2001","unstructured":"Vollebergh WA, Iedema J, Bijl RV, de Graaf R, Smit F, Ormel J. The structure and stability of common mental disorders: the NEMESIS study. Arch Gen Psychiatry. 2001;58(6):597\u2013603.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"153_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archpsyc.56.10.921","volume":"56","author":"RF Krueger","year":"1999","unstructured":"Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56(10):921\u20136.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"153_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1037\/0021-843X.107.2.216","volume":"107","author":"RF Krueger","year":"1998","unstructured":"Krueger RF, Caspi A, Moffitt TE, Silva PA. The structure and stability of common mental disorders (DSM-III-R): a longitudinal-epidemiological study. J Abnorm Psychol. 1998;107(2):216\u201327.","journal-title":"J Abnorm Psychol"},{"issue":"3","key":"153_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s40473-014-0014-1","volume":"1","author":"JR Strawn","year":"2014","unstructured":"Strawn JR, Dominick KC, Patino LR, Doyle CD, Picard LS, Phan KL. Neurobiology of pediatric anxiety disorders. Curr Behav Neurosci Rep. 2014;1(3):154\u201360.","journal-title":"Curr Behav Neurosci Rep."},{"issue":"7","key":"153_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.janxdis.2014.07.012","volume":"28","author":"JR Strawn","year":"2014","unstructured":"Strawn JR, John Wegman C, Dominick KC, Swartz MS, Wehry AM, Patino LR, et al. Cortical surface anatomy in pediatric patients with generalized anxiety disorder. J Anxiety Disord. 2014;28(7):717\u201323.","journal-title":"J Anxiety Disord"},{"issue":"4","key":"153_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000347090","volume":"67","author":"JR Strawn","year":"2013","unstructured":"Strawn JR, Chu WJ, Whitsel RM, Weber WA, Norris MM, Adler CM, et al. A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder. Neuropsychobiology. 2013;67(4):224\u20139.","journal-title":"Neuropsychobiology."},{"key":"153_CR28","doi-asserted-by":"crossref","unstructured":"Roy AK, Fudge JL, Kelly C, Perry JS, Daniele T, Carlisi C, et al. Intrinsic functional connectivity of amygdala-based networks in adolescent generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2013;52(3):290\u20139.e2.","DOI":"10.1016\/j.jaac.2012.12.010"},{"issue":"2","key":"153_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/cap.2009.0049","volume":"20","author":"J Maslowsky","year":"2010","unstructured":"Maslowsky J, Mogg K, Bradley BP, McClure-Tone E, Ernst M, Pine DS, et al. A preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder. J Child Adolesc Psychopharmacol. 2010;20(2):105\u201311.","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"5","key":"153_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/archpsyc.65.5.568","volume":"65","author":"CS Monk","year":"2008","unstructured":"Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM, et al. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry. 2008;65(5):568\u201376.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"153_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/da.21913","volume":"29","author":"JR Strawn","year":"2012","unstructured":"Strawn JR, Wehry AM, DelBello MP, Rynn MA, Strakowski S. Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. Depress Anxiety. 2012;29(4):328\u201339.","journal-title":"Depress Anxiety"},{"key":"153_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.janxdis.2015.03.004","volume":"32","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Hamm L, Fitzgerald DA, Fitzgerald KD, Monk CS, Phan KL. Neurostructural abnormalities in pediatric anxiety disorders. J Anxiety Disord. 2015;32:81\u20138.","journal-title":"J Anxiety Disord"},{"issue":"2","key":"153_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jaac.2012.11.016","volume":"52","author":"SC Mueller","year":"2013","unstructured":"Mueller SC, Aouidad A, Gorodetsky E, Goldman D, Pine DS, Ernst M. Gray matter volume in adolescent anxiety: an impact of the brain-derived neurotrophic factor Val(66)Met polymorphism? J Am Acad Child Adolesc Psychiatry. 2013;52(2):184\u201395.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"153_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1176\/ajp.2007.164.2.290","volume":"164","author":"MA Rynn","year":"2007","unstructured":"Rynn MA, Riddle MA, Yeung PP, Kunz NR. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry. 2007;164(2):290\u2013300.","journal-title":"Am J Psychiatry."},{"issue":"4","key":"153_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","volume":"42","author":"B Birmaher","year":"2003","unstructured":"Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, et al. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2003;42(4):415\u201323.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"153_CR36","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","volume":"158","author":"MA Rynn","year":"2001","unstructured":"Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry. 2001;158(12):2008\u201314.","journal-title":"Am J Psychiatry."},{"issue":"26","key":"153_CR37","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","volume":"359","author":"JT Walkup","year":"2008","unstructured":"Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753\u201366.","journal-title":"N Engl J Med."},{"issue":"2","key":"153_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ebch.541","volume":"5","author":"JC Ipser","year":"2010","unstructured":"Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Cochrane review: pharmacotherapy for anxiety disorders in children and adolescents. Evid Based Child Health Cochrane Rev J. 2010;5(2):555\u2013628.","journal-title":"Evid Based Child Health Cochrane Rev J."},{"issue":"3","key":"153_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaac.2014.12.015","volume":"54","author":"MA Rynn","year":"2015","unstructured":"Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, et al. Child\/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry. 2015;54(3):180\u201390.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"15","key":"153_CR40","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","volume":"297","author":"JA Bridge","year":"2007","unstructured":"Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683\u201396.","journal-title":"JAMA"},{"key":"153_CR41","unstructured":"US Food and Drug Administration. Relationship between psychotropic drugs and pediatric suicidality: review and evaluation of clinical data. Available at: \n                    http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/2004-4065b1-10-TAB08-Hammads-Review.pdf\n                    \n                  ."},{"issue":"1","key":"153_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00213-006-0642-6","volume":"191","author":"WK Goodman","year":"2007","unstructured":"Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology. 2007;191(1):87\u201396.","journal-title":"Psychopharmacology"},{"issue":"8","key":"153_CR43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38(8):1083\u2013152.","journal-title":"Neuropharmacology"},{"key":"153_CR44","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1038\/tp.2015.57","volume":"5","author":"KA Rahn","year":"2015","unstructured":"Rahn KA, Cao YJ, Hendrix CW, Kaplin AI. The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression. Transl Psychiatry. 2015;5:e563.","journal-title":"Transl Psychiatry."},{"issue":"2","key":"153_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000370338","volume":"84","author":"GA Fava","year":"2015","unstructured":"Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom. 2015;84(2):72\u201381.","journal-title":"Psychother Psychosom"},{"key":"153_CR46","unstructured":"Hosenbocus S, Chahal R. SSRIs and SNRIs: a review of the discontinuation syndrome in children and adolescents. J Can Acad Child Adolesc Psychiatry\u00a0=\u00a0Journal de l\u2019Academie canadienne de psychiatrie de l\u2019enfant et de l\u2019adolescent. 2011;20(1):60\u20137."},{"issue":"4","key":"153_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaac.2015.01.008","volume":"54","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, et al. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(4):283\u201393.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"153_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.chi.0000246070.23695.06","volume":"46","author":"SD Connolly","year":"2007","unstructured":"Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(2):267\u201383.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"153_CR49","doi-asserted-by":"crossref","unstructured":"Pine DS. Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate? J Child Adolesc Psychopharmacol. 2002;12(3):189\u2013203.","DOI":"10.1089\/104454602760386888"},{"issue":"3","key":"153_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2165\/00148581-200911030-00003","volume":"11","author":"CP Keeton","year":"2009","unstructured":"Keeton CP, Kolos AC, Walkup JT. Pediatric generalized anxiety disorder: epidemiology, diagnosis, and management. Paediatr Drugs. 2009;11(3):171\u201383.","journal-title":"Paediatr Drugs"},{"key":"153_CR51","doi-asserted-by":"crossref","unstructured":"Tanno S, Ohhira M, Tsuchiya Y, Takeuchi T, Tanno S, Okumura T. Frequent early discontinuation of SSRI prescribed by primary care physicians in young males in Japan. Intern Med (Tokyo, Japan). 2009;48(15):1263\u20136.","DOI":"10.2169\/internalmedicine.48.2018"},{"key":"153_CR52","unstructured":"Sparks JA, Duncan BL. Outside the black box: re-assessing pediatric antidepressant prescription. J Can Acad Child Adolesc Psychiatry\u00a0=\u00a0Journal de l\u2019Academie canadienne de psychiatrie de l\u2019enfant et de l\u2019adolescent. 2013;22(3):240\u20136."},{"issue":"3","key":"153_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/da.22329","volume":"32","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015;32(3):149\u201357.","journal-title":"Depress Anxiety"},{"issue":"6","key":"153_CR54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/archgenpsychiatry.2011.2048","volume":"69","author":"RD Gibbons","year":"2012","unstructured":"Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012;69(6):580\u20137.","journal-title":"Arch Gen Psychiatry"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-015-0153-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0153-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:10:34Z","timestamp":1589670634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-015-0153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1007\/s40272-015-0153-1","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]},"assertion":[{"value":"11 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mr. Dobson has received support from the American Academy of Child and Adolescent Psychiatry (Campaign for America\u2019s Kids) and Dr. Strawn has received support from the National Institute of Mental Health (K23 MH106037). No sources of funding were used to assist with the preparation of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Strawn has received research support from Edgemont, Eli Lilly, Shire, Forest Research Institute, Lundbeck and receives royalties from Springer Publishing for two texts, has produced a rating scale training video for Neuronetics and has received material support from Assurx. Dr. Dobson has no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}